Someya Toshiyuki

2009 - 2011 Large scale prevalence study and Exploring biological marker by long-term follow-up study for PDD/ARMS

2009 - 2010 Copy number variation and risk of schizophrenia : a genome-wide analysis in a multiplex pedigree

2008 - 2010 Predictors of side effects induced by second generation antipsychotics

2005 - 2009 A Search for Risk Genes of Psychiatric Disorders

2007 - 2008 The effect of newel antipsychotic drugs on the Incidente of metabolic syndrome

2007 - 2008 Pharmacogenomics of antidepressant response and adverse effects

2005 - 2006 The search of the gene polymorphism associated with glycolipid metabolism dysfunction in schizophrenic patients with novel antipsychotics

2003 - 2004 A search for glucose intolerance related gene associated with atypical antipsychotics-induced adverse effects

2001 - 2002 The development of custom-made therapy of depression used genomic analysis concerned with the response of drug therapy

2000 - 2001 Schizophrenic Abnormality in Molecular Signaling and RNA Expression Profiling

1999 - 2000 THE ASSOCIATION BETWEEN IMPULSIVENESS/AGGRESSIVENESS AND SEROTONIN RELATED GENE POLYMORPHISM

1999 - 2000 精神分裂病とそのモデルとしてのノックアウトマウスの総合的比較・分析

1998 - 1999 Molecular pharmacogenetic study on the marker for drug response in refractory depressive patients

1997 - 1999 Clnical pharmacological and molecular genetic study on the development of rational antipsychotic therapy

1995 - 1997 Molecular pharmacogenetic investigation of pharmacotherapeutic strategy for treatment-resistant depression.

1994 - 1994 SPECTを用いた気分障害患者の局所脳血流異常の解析と治療反応性予測の検

1991 - 1991 ヒト赤血球ハロペリドール還元酵素の精製と特性分析

1990 - 1990 ハロペリドール・還元型ハロペリドールの血漿中および赤血球中濃度とその臨床的意義

1989 - 1989 精神疾患患者におけるハロペリドール代謝の多型性に関する研究

1987 - 1987 正常者および睡眠障害患者における終夜睡眠経過と睡眠関連ペプチド・ホルモンの動態